Abstract
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.
Cite
CITATION STYLE
APA
Salam, A. P., Cheng, V., Edwards, T., Olliaro, P., Sterne, J., & Horby, P. (2021). Time to reconsider the role of ribavirin in lassa fever. PLoS Neglected Tropical Diseases, 15(7). https://doi.org/10.1371/journal.pntd.0009522
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free